Antitumor activity of rapamycin in a Phase I trial for patients with recurrent PTEN-deficient glioblastoma.
Cloughesy TF; Yoshimoto K; Nghiemphu P; Brown K; Dang J; Zhu S; Hsueh T; Chen Y; Wang W; Youngkin D; Liau L; Martin N; Becker D; Bergsneider M; Lai A; Green R; Oglesby T; Koleto M; Trent J; Horvath S; Mischel PS; Mellinghoff IK; Sawyers CL; Plos Medicine, 2008, vol. 5, issue 1, p e8, ISSN 15491676. ISBN 15491676.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef